October 2, 2026

Real Estate

Technology

Atara resubmits Ebvallo BLA to FDA

After a year of struggling to reach the finish line, Thousand Oaks-based Atara Biotherapeutics is knocking on the door again. The biotech company, which is aiming to create therapies for patients with cancer and autoimmune diseases, announced Sept. 30 that it has resubmitted the tabelecleucel Biologics License Application to the U.S. Food and Drug Administration, alongside its partner Pierre Fabre Pharmaceuticals. Tabelecleucel, sold under the brand name Ebvallo, is a Read More >

Newsmakers

Sponsored Content
Gregory Shamoon

J.P. Morgan Private Bank

Kyle Bobo

J.P. Morgan Private Bank

Jason Williams

Fifth Third Bank

Mack Carlson

Brownstein Hyatt Farber Schreck

ADVERTISING

Reach our audience with your message

Pacific Coast Business Times provides marketers with access to an affluent, educated business community of decision-makers via multimedia formats. Whichever media format or combination of media you choose, the Business Times helps you reach your marketing and sales goals.

Connect with our audience

94%

Answered the Business Times had influenced their buying decisions.

92%

Read the Pacific Coast Business Times for business news.

78%

Have obtained a four-year college degree.